Header Logo

Connection

PADMANEE SHARMA to Anilides

Back to Details
This is a "connection" page, showing publications PADMANEE SHARMA has written about Anilides.
PADMANEE SHARMA
Connection Strength
0.072
Anilides
  1. A phase 1-2 trial of sitravatinib and nivolumab in clear cell renal cell carcinoma following progression on antiangiogenic therapy. Sci Transl Med. 2022 04 20; 14(641):eabm6420.
    View in: PubMed
    Score: 0.042
  2. Effective combinatorial immunotherapy for castration-resistant prostate cancer. Nature. 2017 03 30; 543(7647):728-732.
    View in: PubMed
    Score: 0.030
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.